After analyzing more than 10 million drug tests, Quest Diagnostics released their annual Drug Testing Index, which revealed that workforce drug positivity is at its highest rate in a decade. 4.2 percent of the combined U.S. workforce tested positive in 2017. These findings also showed increases in cocaine, marijuana and methamphetamine use. Marijuana positivity was up the most in states with new legalization statutes. While cocaine and methamphetamine use increased, prescription opiates have seen a decline.
"It's unfortunate that we mark 30 years of the Drug-Free Workplace Act with clear evidence that drugs continue to invade the country's workplaces," Barry Sample, senior director of science and technology at Quest Diagnostics, said in the report. "Not only have declines appeared to have bottomed out, but also in some drug classes and areas of the country drug positivity rates are increasing. These changing patterns and geographical variations may challenge the ability of employers to anticipate the 'drug of choice' for their workforce or where to best focus their drug prevention efforts to ensure a safe and healthy work environment."
Read the Quest Diagnostics report on the findings here.